Eli Lilly and Company (LLY.DE)

EUR 740.8

(-1.23%)

Operating Expenses Summary of Eli Lilly and Company

  • Eli Lilly and Company's latest annual operating expenses in 2023 was 20.05 Billion USD , up 19.25% from previous year.
  • Eli Lilly and Company's latest quarterly operating expenses in 2024 Q2 was 4.71 Billion USD , up 8.15% from previous quarter.
  • Eli Lilly and Company reported a annual operating expenses of 13.63 Billion USD in annual operating expenses 2022, up 1.29% from previous year.
  • Eli Lilly and Company reported a annual operating expenses of 13.45 Billion USD in annual operating expenses 2021, up 10.25% from previous year.
  • Eli Lilly and Company reported a quarterly operating expenses of 4.83 Billion USD for 2024 Q3, up 96.61% from previous quarter.
  • Eli Lilly and Company reported a quarterly operating expenses of 4.35 Billion USD for 2024 Q1, up 8.28% from previous quarter.

Annual Operating Expenses Chart of Eli Lilly and Company (2023 - 1989)

Historical Annual Operating Expenses of Eli Lilly and Company (2023 - 1989)

Year Operating Expenses Operating Expenses Growth
2023 20.05 Billion USD 19.25%
2022 13.63 Billion USD 1.29%
2021 13.45 Billion USD 10.25%
2020 12.2 Billion USD 3.37%
2019 11.8 Billion USD 7.1%
2018 11.02 Billion USD -7.11%
2017 11.86 Billion USD 1.49%
2016 11.69 Billion USD 3.23%
2015 11.32 Billion USD -0.22%
2014 11.35 Billion USD -10.29%
2013 12.65 Billion USD -1.05%
2012 12.79 Billion USD -0.85%
2011 12.9 Billion USD 8.07%
2010 11.93 Billion USD 6.41%
2009 11.21 Billion USD 7.18%
2008 10.46 Billion USD 9.24%
2007 9.58 Billion USD 19.49%
2006 8.01 Billion USD 6.6%
2005 7.52 Billion USD 7.84%
2004 6.97 Billion USD 8.89%
2003 6.4 Billion USD 14.93%
2002 5.57 Billion USD -1.4%
2001 5.65 Billion USD 7.73%
2000 5.24 Billion USD 5.34%
1999 4.98 Billion USD 1.91%
1998 4.88 Billion USD 16.2%
1997 4.2 Billion USD 12.92%
1996 3.72 Billion USD 7.97%
1995 3.45 Billion USD 29.25%
1994 2.66 Billion USD -37.03%
1993 4.23 Billion USD 21.71%
1992 3.48 Billion USD 33.82%
1991 2.6 Billion USD 9.52%
1990 2.37 Billion USD 19.76%
1989 1.98 Billion USD 4.98%

Peer Operating Expenses Comparison of Eli Lilly and Company

Name Operating Expenses Operating Expenses Difference
Bayer Aktiengesellschaft 27.88 Billion EUR 28.09%
Sanofi 23.94 Billion EUR 16.238%